Abstract：Objective To evaluate the nutritional status of elderly medicine patients with MNA-SF， to analyze the relationship between nutritional status， sarcopenia and other related factors， and to propose better clinical strategies on the evidences of nutrition treatment for elderly patients. Methods A total of 200 cases of patients aged more than 65 older who received treatment in the elderly medicine of the first affiliated hospital of Kangda college of Nanjing medical university from June 2017 to December 2017 were enrolled in this study. According to the scores of MNA-SF， the patients were divided into normal nutritional group， risk of malnutrition group and malnutrition group. The body composition was measured by body composition analyzer and in the meantime， grip strength， stride speed and laboratory index were evaluated. Results Among the 200 elderly medicine patients， the incidence of normal nutritional status， the risk of malnutrition and malnutrition were 50.5%， 26.5% and 23.0%， respectively. The prevalence of sarcopenia was significantly different between three groups， and the prevalence of sarcopenia in malnutrition group was higher than that in the risk of malnutrition group and the normal nutrition group (P<0.05). The levels of albumin， prealbumin， hemoglobin， body mass index， skeletal muscle， appendicular skeletal muscle mass index， grip strength and stride speed were significantly different between three groups (P<0.05). Conclusions There is a high proportion of malnutrition risk and malnutrition in elderly patients. Patients with malnutrition were more likely to suffer from sarcopenia. Timely nutritional treatment is necessary.
易海维，李文丽，郁云兰，马东波. 老年住院患者营养不良与肌肉减少症及相关因素的分析[J]. 肿瘤代谢与营养电子杂志, 2019, 6(2): 225-229.
YI Hai-wei， LI Wen-li， YU Yun-lan， MA Dong-bo. The relative factors analysis of malnutrition status and sarcopenia in elderly patients. Electron J Metab Nutr Cancer, 2019, 6(2): 225-229.
1.Von Haeling S， Morley JE， Anker SD.An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010；1(2):129-133.
2.Baumgartner RN， Koehler KM， Gallagher D， et al. Epidemiology of sarcopenia among the elderly in new mexico. Am J Epidemiol. 1998；147(8):755-763.
3.Bortz WM 2nd. A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci. 2002；57(5):283-288.
4.Fielding RA， Vellas B， Evans WJ， et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence， etiology， and consequence. International group on sarcopenia. J Am Med Dir Assoc. 2011；12(4):249-256.
5.Cruz-Jentoft AJ， Baeyens JP， Bauer JM， et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010；39(4):412-423.
6.Chen LK， Liu LK， Woo J， et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014；15(2):95-101.
7.Wang H， Hai S， Cao L， et al. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people.BMC Geriatr. 2016；16(1):216.
8.Agarwal E， Miller M， Yaxley A， et al. Malnutrition in the elderly: a narrative review. Maturitas. 2013；76(4):296-302.
9.老年患者肠内外营养支持中国专家共识. 中华老年医学杂志. 2013；32(9):913-929.
10.Dent E， Visvanathan R， Piantadosi C， et al. Use of the mini nutritional assessment to detect frailty in hospitalized older people. J Nutr Health Aging. 2012；16(9):764-767.
11.Isenring EA， Banks M， Ferguson M， et al. Beyond malnutrition screening: appropriate methods to guide nutrition care for aged care residents. J Acad Nutr Diet. 2012；112(3):376-381.
12.Kyle UG， Kossovsky MP， Karsegard VL， et al. Comparison of tools for nutritional assessment and screening at hospital admission:a population study. Clin Nutr. 2006；25(3):409-417.
13.Lei Z， Qingyi D， Feng G， et al. Clinical study of mini-nutritional assessment for older Chinese inpatients. J Nutr Health Aging. 2009；13(10):871-875.
14.Cabrerizo S， Cuadras D， Gomez BF， et al. Serum albumin and health in older people:review and meta analysis. Maturitas. 2015；81(1):17-27．
15.Seo SH， Kim SE， Kang YK， et al. Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients. BMC Cancer. 2016；16(1):900.
16.Dent E， Morley JE， Cruz-Jentoft AJ， et al. International clinical practice guidelines for sarcopenia (ICFSR):screening， diagnosis and management. J Nutr Health Aging. 2018；22(10):1148-1161.
17.Volpi E， Sheffieldmoore M， Rasmussen BB， et al. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA. 2011；286(286):1206-1212.
18.Visser M， Deeg DJ， Lips P， et al. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia):the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003；88(12):5766-5772.
19.Boirie Y， Guillet C. Fast digestive proteins and sarcopenia of aging. Current opinion in clinical nutrition and metabolic care. 2018；21(1):37-41.
20.Kobayashi H， Borsheim E， Anthony TG， et al. Reduced amino acid availability inhibits muscle protein synthesis and disease activity of initiation factor eIF2B. Am J Physiol Endocrinol Metab. 2003；284(3):E488-E498.
21.Cruz-Jentoft AJ， Bahat G， Bauer J， et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019； 48(1):16-31.
22.Wannamethee SG， Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc. 2015；74 (4):405-412.
